Dual pH-responsive and CD44 receptor targeted multifunctional nanoparticles for anticancer intracellular delivery
Source abstract
Abstract
In this article, we prepared a multifunctional oligosaccharides of hyaluronan (oHA) conjugates, oHA-histidine-menthone 1,2-glycerol ketal (oHM). The oHM conjugates possess pH-sensitive menthone 1,2-glycerol ketal (MGK) as hydrophobic moieties and oHA as the target of CD44 receptor. The polymeric mPEG-Chitosan-Ketal (PCK) carrying pH-sensitive ketal group as hydrophobic moieties and PEG group as hydrophilic moieties were synthesized. The two pH-sensitive ketal derivatives were employed to fabricate nanoparticles for anti-tumor drug delivery. The oHM-PCK nanoparticles (oHPN) can spontaneously self-assemble into mixed micellar structure with nano-sized spherical shape of 100–200 nm at pH 7.4 PBS conditions. The oHPN could release encapsulated curcumin with 92.6 % at pH 5.0 compared with 55.3 % at pH 7.4. The results of cytotoxicity assay indicated that encapsulated curcumin in oHPN (Cur-oHPN) have less toxicity compared to curcumin suspension. The anti-tumor efficacy in vivo suggested that Cur-oHPN suppressed tumor growth most efficiently. These results present the promising potential of oHPN as an effective nano-sized pH-sensitive drug delivery system for intracellular delivery.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (16)
Show source-provided references
1. Camenisch TD, McDonald JA (2000) Hyaluronan: is bigger better? Am J Respir Cell Mol Biol 3:431–43310.1165/ajrcmb.23.4.f201 ↗
2. Chen D, Wang H (2014) Novel pH-sensitive biodegradable polymeric drug delivery systems based on ketal polymers. J Nanosci Nanotechnol 14(983–989):7
3. Chen D, Jiang X, Liu J, Jin X, Zhang C, Ping Q (2010) In vivo evaluation of novel pH-sensitive mPEG-Hz-chol conjugate in liposomes: pharmacokinetics, tissue distribution, efficacy assessment. Artif Cells Blood Substit Immobil Biotechnol 38:136–14210.3109/10731191003685481 ↗
4. Chen D, Liu W, Shen Y, Mu H, Zhang Y, Liang R et al (2011) Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon. Int J Nanomed 6:2053–206110.2147/IJN.S24344 ↗
5. Chen D, Sun K, Mu H, Tang M, Liang R, Wang A et al (2012) pH and temperature dual-sensitive liposome gel based on novel cleavable mPEG-Hz-CHEMS polymeric vaginal delivery system. Int J Nanomed 7:2621–263010.2147/IJN.S31757 ↗
6. Chen D, Mu H, Sun K, Liu W (2013a) Synthesis, anticoagulant activity and potential drug carrier of biomimetic N-cholesteryl hemisuccinate-O-sulfate chitosan polymer of blood cell membrane. J Control Release. 172:e2510.1016/j.jconrel.2013.08.058 ↗
7. Chen D, Yu H, Mu H, Wei J, Song Z, Shi H et al (2013b) Novel chitosan derivative for temperature and ultrasound dual-sensitive liposomal microbubble gel. Carbohydr Polym 94:17–2310.1016/j.carbpol.2012.12.069 ↗
8. Duncan R (2006) Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6:688–70110.1038/nrc1958 ↗
9. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP et al (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95:4607–461210.1073/pnas.95.8.4607 ↗
10. Hou L, Yao J, Zhou J, Zhang Q (2012) Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system. Biomaterials 3:5431–544010.1016/j.biomaterials.2012.03.070 ↗
11. Kim JH, Kim YS, Kim S, Park JH, Kim K, Choi K et al (2006) Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release 111:228–23410.1016/j.jconrel.2005.12.013 ↗
12. Kothapalli D, Flowers J, Xu T, Puré E, Assoian RK (2008) Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44. J Biol Chem 283:31823–3182910.1074/jbc.M802934200 ↗
13. Park K, Kim JH, Nam YS, Lee S, Nam HY, Kim K et al (2007) Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J Control Release 122:305–31410.1016/j.jconrel.2007.04.009 ↗
14. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H et al (2006) Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 26:58–6810.1016/j.matbio.2006.08.261 ↗
15. Yang C, Cao M, Liu H, He Y, Xu J, Du Y et al (2012) The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 287:43094–4310710.1074/jbc.M112.349209 ↗
16. Yu H, Mu H, Xiu L, Sun K, Liu W, Chen D (2013) A novel ketal-based chitosan as nano-vehicles for potential pH-sensitive nanomedicine delivery. Nanosci Nanotechnol Lett 5:1007–101110.1166/nnl.2013.1660 ↗